Head & Neck Cancer

Cancer survivors worry about recurrence, but seldom think about their risk for new primaries.

Patients with head and neck cancer experienced a decrease in symptom severity after using mobile and sensor technology that allowed their health care providers to remotely monitor symptoms, according to research that will be presented at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting.

When compared to chemotherapy, the immunotherapy agent had better outcomes both in quality of life and survival.

Higher carbohydrate and sugar intake was correlated with worse outcomes in patients with head and neck cancer, according to the study.

The Food and Drug Administration (FDA) approved the two-drug combination Tafinlar (dabrafenib) and Mekinist (trametinib) to treat patients with metastatic or unresectable anaplastic thyroid cancer (ATC), whose tumors harbor the BRAF V600E mutation.

After being diagnosed with a rare cancer, professional runner Gabriele Grunewald became inspired to start a nonprofit that raised awareness for other rare cancers and empowered those who have them.

I found my husband there in the dream. He was alive. He was healthy. He could talk again.

After a recent FDA approval for an additional dosing schedule option for Opdivo, patients must be educated on the potential side effects that may occur between prolonged visits.

NFL Hall of Famer Jim Kelly confirmed his cancer has returned, according to recently issued statements from the Buffalo Bills.
 

These findings bring light to a pressing problem in this patient population, and will hopefully pave the way for more awareness and potential change in practices.